TCMP
HALO icon

Thrive Capital Management (Pennsylvania)’s Halozyme HALO Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.96M Buy
63,376
+11,744
+23% +$801K 0.94% 26
2026
Q1 		$3.34M Buy
+51,632
New +$3.64M 0.73% 67

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s HALO Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Halozyme (HALO) stake by 23% in Q2 2026, buying an estimated $801K and bringing the position to 63,376 shares worth $4.96M. The position accounts for 0.94% of the portfolio, ranked #26.

Thrive Capital Management (Pennsylvania) first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 63,376 shares of Halozyme worth $4.96M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 11,744 Halozyme shares in Q2 2026, an estimated $801K.
  • Halozyme made up 0.94% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #26 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.